DORMOSEDAN DIN 01927027
Health Canada record
| Active ingredient(s) | DETOMIDINE HYDROCHLORIDE 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1992 |
| Current status date | 31-Dec-1992 |
| Source | Health Canada DPD |
Establishment licence of the holder
Orion Oyj / Orion Corporation / Orion Pharma — licence , not currently licensed, last inspection rating C (2024-11-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DETOMIDINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02335441 | CEPESEDAN | MODERN VETERINARY THERAPEUTICS LLC | Solution | DETOMIDINE HYDROCHLORIDE 10 MG | Marketed |
| 02485303 | DOMIDINE | EUROVET ANIMAL HEALTH B.V. | Solution | DETOMIDINE HYDROCHLORIDE 10 MG | Marketed |
| 02355957 | DORMOSEDAN GEL | ORION CORPORATION | Gel | DETOMIDINE HYDROCHLORIDE 7.6 MG | Marketed |
International API supply for DETOMIDINE HYDROCHLORIDE
16 active FDA Drug Master Files.
Request a quote for DORMOSEDAN